First-phase ejection fraction, a possible indicator of heart failure, is a strong predictor of survival in hospitalized COVID-19 patients, according to a new study. Hospitalized patients who had impaired first-phase ejection fraction were nearly 5 times more likely to die from COVID-19 compared to patients with normal first-phase ejection fraction.